Luo Bo,Zhang Qu,Deng Kangli,Cui Diansheng,Xiong Zhiguo,Wei Shaozhong.Investigation on concurrent chemoradiotherapy for postoperative inguinal recurrence in penile cancer patients[J].Chinese Journal of Radiological Medicine and Protection,2019,39(12):916-919
Investigation on concurrent chemoradiotherapy for postoperative inguinal recurrence in penile cancer patients
Received:March 12, 2019  
DOI:10.3760/cma.j.issn.0254-5098.2019.12.007
KeyWords:Penile cancer  Inguinal lymph node  Chemoradiotherapy  Local recurrence
FundProject:湖北省自然科学基金(2018CFC848,2016CFB217);国家自然科学基金(81201795)
Author NameAffiliationE-mail
Luo Bo Department of Radiotherapy Center, Hubei Cancer Hospital, Wuhan 430079, China  
Zhang Qu Department of Radiotherapy Center, Hubei Cancer Hospital, Wuhan 430079, China  
Deng Kangli Department of Urology, Hubei Cancer Hospital, Wuhan 430079, China  
Cui Diansheng Department of Urology, Hubei Cancer Hospital, Wuhan 430079, China hbzls2020@sina.com 
Xiong Zhiguo Department of Urology, Hubei Cancer Hospital, Wuhan 430079, China  
Wei Shaozhong Department of Urology, Hubei Cancer Hospital, Wuhan 430079, China  
Hits: 1970
Download times: 1115
Abstract::
      Objective To investigate treatment option of inguinal lymph node metastasis after inguinal lymph node dissection in patients with penile cancer. Methods To retrospectively analyze the efficacy and prognostic factors of cisplatin combined with fluorouracil in the concurrent chemoradiotherapy of inguinal lymph node metastasis after penile cancer surgery. Twenty-three patients with inguinal lymph node metastasis after inguinal lymph node dissection for penile squamous cell carcinoma from February 2009 to December 2015 were included.Inguinal lymph node metastasis with squamous cell carcinoma were confirmed by pathology or cytology. Metastatic lymph nodes of each patient were fixed, not less than 2, and greater than 4 cm in diameter. All patients received concurrent chemoradiotherapy with cisplatin and 5-fluorouracil.The response rate was evaluated after radiotherapy. The local control rate, survival time and the prognostic factors were also analyzed. Results The median time of postoperative inguinal lymph node metastasis was 6.1 months, and the recurrence rate of the patients within 16 months after the operation was 95%.The response rate was 65.2% (15/23).After treatment, the local pain was significantly relieved and 7 cases of local hemorrhage was relieved. The 1-,2-year survival rates were 21.3% and 5.5%, respectively, with a median survival of 6.3 months(95% CI:3.4-8.1). And local tumor response rate correlated with radiation dose. Cox multivariate analysis showed that N staging and histological grade were independent prognostic factors for survival after treatment. Conclusions Concurrent chemoradiotherapy is effective for postoperative inguinal lymph node metastasis, especially for the local recurrence with symptoms and for patients who are not suitable for surgical salvage regarding the local tumor control, pain relief and tumor hemorrhage. However, the overall survival rate of the patients who received treatment was still low. Lower extremity edema is the main complication of concurrent chemoradiotherapy. N staging and poor differentiation of the tissue are unfavorable prognostic factors.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:9077751  On-line:0

v
Scan QR Code
&et=9A2B3ECE8B55D590F309F17E6178CC7F54417724E52A6E8614CF2B38C041C56A788AB2C20DCF6980D4B8E645A8D40C42000AD8A6CBCEAA837D168982579398BBFE82FF7A2E6903F66FB37BE892BD6C0AEBE95213A35ABC5F8CB8D7EEDC2FFF67F8DB5556792411E65DEFC0921F3E18BF&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=B6351343F4791CA3&aid=7BA62EAAEF4CF3CA6A2F4C136C24A5B9&vid=&iid=59906B3B2830C2C5&sid=DE4E739E935BD9A7&eid=46DFDABDAA819280&fileno=20191207&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="B6351343F4791CA3"; var my_aid="7BA62EAAEF4CF3CA6A2F4C136C24A5B9";